Keyword: Institute of Biomedicine

This page displays contents related to the keyword.

Terveydeksi!-seminaari/New Discoveries!-seminar

Time

24.4.2019 at 8.00 - 26.4.2019 at 15.00
Terveydeksi - New Discoveries 2019! -biolääketieteen opinnäytetyöseminaari järjestetään tänä vuonna 24.-26.4. 2019, Medisiina D:n Alhopuro-salissa. Seminaarissa esitetään suullisesti biolääketieteen / terveyden biotieteiden Pro gradu -tutkielmia ja LuK -tutkielmia. Seminaari on kaikille avoin. Lue...

Lifespan minisymposium, The Journey of PET imaging

Time

14.12.2018 at 12.15 - 14.45
Lifespan minisymposium: The Journey of PET imaging12.15 Keynote Speaker: Prof. Anna-Liisa Brownell, PhDHarvard Medical School, Massachusetts General Hospital, Boston“From Man to Mouse to Man – Journey of PET Imaging”13.15 – 13.45 Coffee break13.45 – 14.15 Mirkka Sarparanta, PhD, Academy Research...

Gut microbiota Not Involved in the Incidence of Gestational Diabetes Mellitus – But Gut Microbiota May Be Modulated by Fish Oil And Probiotics

09.09.2020

Consuming the combination of fish oil and probiotic food supplements modulate the composition of gut microbiota in overweight and obese pregnant women, reveals a new study conducted at the University of Turku, Finland. The same study shows that gut microbiota composition and function is not related to gestational diabetes.

US Department of Defense Supports Breast Cancer Research at the Turku Bioscience Centre

27.04.2020

Despite of continuous development in breast cancer treatments, metastases of the most aggressive breast cancer types are still a significant and growing medical problem. Together with a research group at Michigan University, the group of Professor Jukka Westermarck at Turku Bioscience Centre recently received funding from the US Department of Defense for the development of novel treatment strategies for breast cancer metastases.

Changes Associated with Alzheimer’s Disease Detectable in Blood Samples

11.10.2019

Researchers have discovered new changes in blood samples which are associated with Alzheimer’s disease. A new international study examined Finnish twins. The study was conducted on disease-discordant twin pairs: one sibling who suffered from Alzheimer’s disease and one who was cognitively healthy. The researchers utilised the latest genome-wide methods to find out whether the twins’ blood samples had any disease-related differences in chemical marks, so-called epigenetic marks, which are sensitive to changes in environmental and lifestyle factors.